EichorEICHOR
Location: New Orleans Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near New Orleans

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Children's Hospital New Orleans · National Cancer Institute (NCI) · NCT05099003Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Hospital New Orleans · National Cancer Institute (NCI) · NCT06172296Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Louisiana State University Health Science Center · NRG Oncology · NCT05624996Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · Louisiana State University Medical Sciences Center in New Or · Robert G. Grossman, MD · NCT00178724A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Children's Hospital New Orleans · National Cancer Institute (NCI) · NCT05691478Multicenter HomeVENT: Home Values and Experiences Navigation Track
NA · Children's Hospital New Orleans · Johns Hopkins University · NCT06102330A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · University Medical Center New Orleans ( Site 0024) · Merck Sharp & Dohme LLC · NCT07044297A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Hospital New Orleans · Children's Oncology Group · NCT04322318Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Louisiana State University Health Science Center · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Tulane University School of Medicine · Alliance for Clinical Trials in Oncology · NCT06632327New Orleans Pulmonary Hypertension Biobank
Phase N/A · University Medical Center-New Orleans · Louisiana State University Health Sciences Center in New Orl · NCT03269630COsegregation of VARiants in Panel of Genes
NA · Institut Curie · NCT01689584ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · University Medical Center New Orleans · Alliance for Clinical Trials in Oncology · NCT06876714Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
NA · Children's Hospital of New Orleans/ Tulane University · Michigan State University · NCT06232304A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · Ochsner Health Center for Children - New Orleans · BioMarin Pharmaceutical · NCT06309979Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · University Medical Center New Orleans · Canadian Cancer Trials Group · NCT06592924A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · Velocity Clinical Research - New Orleans · Pfizer · NCT06866405A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Children's Hospital New Orleans · Children's Oncology Group · NCT04293562E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · University Medical Center New Orleans · NRG Oncology · NCT06748222A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With
Phase 3 · Children's Hospital - New Orleans · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT04782258A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · Children's Hospital New Orleans · Children's Oncology Group · NCT05711667Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Louisiana State University Health Science Center · Alliance for Clinical Trials in Oncology · NCT04242095Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · University Medical Center New Orleans · Canadian Cancer Trials Group · NCT05640999Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · University Medical Center New Orleans · National Cancer Institute (NCI) · NCT05256225A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopat
Phase 2/Phase 3 · Children's Hospital New Orleans · Cytokinetics · NCT06412666Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · University Medical Center New Orleans · National Cancer Institute (NCI) · NCT06498635Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · University Medical Center New Orleans · ECOG-ACRIN Cancer Research Group · NCT07001748Project: Every Child for Younger Patients With Cancer
Phase N/A · Children's Hospital New Orleans · Children's Oncology Group · NCT02402244Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · Louisiana State University Health Science Center · NRG Oncology · NCT05646316Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Louisiana State University Health Science Center · Eastern Cooperative Oncology Group · NCT05108298
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.